These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16538590)

  • 1. [Subacute sclerosing panencephalitis: combined treatment with interferon alpha and intraventricular ribavirin].
    del Toro-Riera M; Macaya-Ruiz A; Raspall-Chaure M; Tallada-Serra M; Pasqual-López I; Roig-Quilis M
    Rev Neurol; 2006 Mar 1-15; 42(5):277-81. PubMed ID: 16538590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy and prognosis in subacute sclerosing panencephalitis].
    Hosoya M
    Nihon Rinsho; 2007 Aug; 65(8):1483-6. PubMed ID: 17695288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis.
    Hosoya M; Mori S; Tomoda A; Mori K; Sawaishi Y; Kimura H; Shigeta S; Suzuki H
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4631-5. PubMed ID: 15561836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with intraventricular interferon-alpha and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay.
    Hara S; Kimura H; Hoshino Y; Hayashi N; Negoro T; Okumura A; Kajita Y; Sakuma T; Nakayama T; Hosoya M; Tomoda A; Morisima T
    Brain Dev; 2003 Aug; 25(5):367-9. PubMed ID: 12850518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti SSPE drugs].
    Hosoya M
    Nihon Rinsho; 2012 Apr; 70(4):625-8. PubMed ID: 22568144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trial of intraventricular ribavirin and interferon-alpha combination therapy for subacute sclerosing panencephalitis (SSPE) in Japan].
    Tomoda A; Nomura K; Shiraishi S; Miike T; Hamada A; Hosoya M
    No To Hattatsu; 2003 Jul; 35(4):321-6. PubMed ID: 12875209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
    Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
    J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis.
    Hosoya M; Shigeta S; Mori S; Tomoda A; Shiraishi S; Miike T; Suzuki H
    Antimicrob Agents Chemother; 2001 Mar; 45(3):943-5. PubMed ID: 11181386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan.
    Anlar B
    Brain Dev; 2004 Aug; 26(5):345; author reply 345-6. PubMed ID: 15165678
    [No Abstract]   [Full Text] [Related]  

  • 10. Favorable outcomes of interferon-α and ribavirin treatment for a male with subacute sclerosing panencephalitis.
    Sonoda Y; Sonoda M; Yonemoto K; Sanefuji M; Taira R; Motomura Y; Ishimura M; Torisu H; Kira R; Kusuhara K; Sakai Y; Ohga S
    J Neuroimmunol; 2021 Sep; 358():577656. PubMed ID: 34304142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute sclerosing panencephalitis: an update.
    Gutierrez J; Issacson RS; Koppel BS
    Dev Med Child Neurol; 2010 Oct; 52(10):901-7. PubMed ID: 20561004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subacute sclerosing panencephalitis (SSPE)].
    Hosoya M
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1047-50. PubMed ID: 22277474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subacute sclerosing panencephalitis: fulminant form].
    Grippo J; Cáceres L; Asís A; Grippo T; Ruprecht B; López M
    Rev Neurol; 2003 Mar 16-31; 36(6):536-9. PubMed ID: 12652417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo.
    Takahashi T; Hosoya M; Kimura K; Ohno K; Mori S; Takahashi K; Shigeta S
    Antiviral Res; 1998 Jan; 37(1):29-35. PubMed ID: 9497070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serial ¹⁸FDG-PET study of a patient with SSPE who had good prognosis by combination therapy with interferon alpha and ribavirin.
    Ohya T; Yamashita Y; Shibuya I; Hara M; Nagamitsu S; Kaida H; Kurata S; Ishibashi M; Matsuishi T
    Eur J Paediatr Neurol; 2014 Jul; 18(4):536-9. PubMed ID: 24679544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan.
    Tomoda A; Nomura K; Shiraishi S; Hamada A; Ohmura T; Hosoya M; Miike T; Sawaishi Y; Kimura H; Takashima H; Tohda Y; Mori K; Kato Z; Fukushima A; Nishio H; Nezu A; Nihei K
    Brain Dev; 2003 Oct; 25(7):514-7. PubMed ID: 13129596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminating adult-onset subacute sclerosing panencephalitis in a 49-year-old man.
    Gagnon A; Bouchard RW
    Arch Neurol; 2003 Aug; 60(8):1160-1. PubMed ID: 12925376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-interferon in the treatment of subacute sclerosing panencephalitis.
    Fayad MN; Yamout BI; Mroueh S
    J Child Neurol; 1997 Nov; 12(8):486-8. PubMed ID: 9430312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with acute, fulminant form of SSPE.
    Hergüner MO; Altunbaşak S; Baytok V
    Turk J Pediatr; 2007; 49(4):422-5. PubMed ID: 18246746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.